These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30360715)

  • 1. Recent Advancement in the Diagnosis and Treatment of Leprosy.
    Aamir M; Sadaf A; Khan S; Perveen S; Khan A
    Curr Top Med Chem; 2018; 18(18):1550-1558. PubMed ID: 30360715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium leprae and Mycobacterium lepromatosis Infection: a Report of Six Multibacillary Cases of Leprosy in the Dominican Republic.
    Fernández JDP; Pou-Soarez VE; Arenas R; Juárez-Duran ER; Luna-Rojas SL; Xicohtencatl-Cortes J; Martínez-Chavarría LC; Martínez-Hernández F; Hernández-Castro R
    Jpn J Infect Dis; 2022 Jul; 75(4):427-430. PubMed ID: 35354704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy.
    Pinheiro LCS; Borges JC; Campos VR; Dantas LC
    Mini Rev Med Chem; 2023; 23(4):497-512. PubMed ID: 35430972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of leprosy/Hansen's disease in the early 21st century.
    Worobec SM
    Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities.
    Sharma M; Singh P
    Comb Chem High Throughput Screen; 2022; 25(10):1578-1586. PubMed ID: 34620073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant M leprae.
    Saunderson PR
    Clin Dermatol; 2016; 34(1):79-81. PubMed ID: 26773627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for drug target identification in Mycobacterium leprae.
    Acebrón-García-de-Eulate M; Blundell TL; Vedithi SC
    Drug Discov Today; 2021 Jul; 26(7):1569-1573. PubMed ID: 33798649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of leprosy in a nonendemic country.
    Asperges E; Bagnarino J; Ancarani C; Baggini G; Filardo M; Monzillo V; Barbarini D; Bruno R; Paulli M; Baldanti F
    Int J Infect Dis; 2024 Jun; 143():107004. PubMed ID: 38479578
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the diagnosis and treatment of leprosy.
    Katoch VM
    Expert Rev Mol Med; 2002 Jul; 4(15):1-14. PubMed ID: 14585155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.